BeStock  
股票 › 生物科技 › CRSP

CRISPR 制药 CRSP

$50.07 +$1.51 (+3.11%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.35 -1.44%
开盘$48.98
昨收$48.56
当日区间$48.41 – $50.27
成交量1.24M
市值$4.86B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$10.00M+1,041.4% YoY
营业利润-$117.27M+48.9% YoY
净利润-$91.15M+56.3% YoY
摊薄每股收益-$0.94+60.8% YoY
自由现金流-$86.62M+37.7% YoY
经营现金流-$83.50M

营收,近8个季度

$0.0Sep '24$35.0MDec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$1.0MMar '26$10.0MJun '26

净利润,近8个季度

$-85.9MSep '24$-37.3MDec '24$-136.0MMar '25$-208.5MJun '25$-106.4MSep '25$-130.6MDec '25$-122.9MMar '26$-91.2MJun '26

各季度摊薄每股收益

-1.01Sep '24-0.44Dec '24-1.58Mar '25-2.40Jun '25-1.17Sep '25-1.37Dec '25-1.28Mar '26-0.94Jun '26

各季度自由现金流

$-107.1MSep '24$-50.3MDec '24$-54.2MMar '25$-139.0MJun '25$-84.7MSep '25$-93.1MDec '25$-109.4MMar '26$-86.6MJun '26

年度营收

$543.0KFY20$913.1MFY21$436.0KFY22$370.0MFY23$35.0MFY24$0.0FY25

盈利能力与资产负债表

毛利率-1,691.3%
营业利润率-4,857.6%
净利率-4,101.3%
净资产收益率-26.1%
资产收益率-19.3%
投入资本回报率-20.2%
流动比率17.85
负债/资产比率34.1%
现金及投资$2.36B
总负债$765.10M
净现金(净负债)$1.60B

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $10.18M $1.46M $3.51M $864,000.00 $889,000.00
营业总收入 $10.00M $1.00M $0.00 $0.00 $0.00
营业成本 $40.27M $45.95M $213.48M $53.70M $57.12M
毛利润 -$30.27M -$44.95M -$213.48M -$53.70M -$57.12M
营业费用 $87.00M $85.30M $451.09M $101.06M $74.94M
销售及管理费用 $17.55M $17.18M $73.54M $18.40M $16.93M
-管理费用 $17.55M $17.18M $73.54M $18.40M $16.93M
研发费用 $69.63M $68.57M $381.06M $83.53M $58.90M
其他营业费用 -$181,000.00 -$458,000.00 -$3.51M -$864,000.00 -$889,000.00
营业利润 -$117.27M -$130.25M -$664.57M -$154.76M -$132.06M
其他收入(支出) $27.08M $8.16M $86.61M $24.77M $26.24M
其他非经营性收入(支出) $27.08M $8.16M $86.61M $24.77M $26.24M
税前利润 -$90.19M -$122.09M -$577.97M -$130.00M -$105.82M
税费 $960,000.00 $839,000.00 $3.63M $614,000.00 $619,000.00
净利润 -$91.15M -$122.93M -$581.60M -$130.61M -$106.44M
持续经营利润 -$91.15M -$122.93M -$581.60M -$130.61M -$106.44M
归属母公司净利润 -$91.15M -$122.93M -$581.60M -$130.61M -$106.44M
归属普通股股东净利润 -$91.15M -$122.93M -$581.60M -$130.61M -$106.44M
基本每股收益 -$0.94 -$1.28 -$6.47 -$1.37 -$1.17
摊薄每股收益 -$0.94 -$1.28 -$6.47 -$1.37 -$1.17

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $2.65B $2.73B $2.27B $2.27B $2.25B
流动资产合计 $2.37B $2.45B $1.99B $1.99B $1.93B
现金及现金等价物与短期投资 $2.36B $2.44B $1.98B $1.98B $1.92B
-现金及现金等价物 $291.34M $423.31M $347.56M $347.56M $286.50M
-短期投资 $2.07B $2.02B $1.63B $1.63B $1.63B
其他流动资产 $7.42M $6.58M $9.84M $9.84M $13.38M
非流动资产合计 $279.00M $277.46M $279.57M $279.57M $316.22M
固定资产净值 $233.66M $240.85M $247.58M $247.58M $255.49M
-固定资产原值 $333.25M $336.19M $338.63M $338.63M $341.10M
-累计折旧 -$99.59M -$95.34M -$91.05M -$91.05M -$85.61M
其他非流动资产 $45.34M $36.61M $32.00M $32.00M $32.31M
负债合计 $904.22M $911.26M $343.43M $343.43M $329.33M
流动负债合计 $132.90M $136.29M $149.12M $149.12M $118.96M
应付款 $11.80M $14.29M $12.25M $12.25M $15.22M
-应付账款 $11.31M $13.65M $11.14M $11.14M $11.80M
-应付税款合计 $494,000.00 $638,000.00 $1.11M $1.11M $3.43M
一年内应计费用 $70.28M $74.93M $89.41M $89.41M $84.18M
短期债务及融资租赁负债 $18.65M $18.61M $18.58M $18.58M $18.26M
-一年内到期融资租赁负债 $18.65M $18.61M $18.58M $18.58M $18.26M
一年内递延负债 $15.19M $15.34M $15.77M $15.77M $1.30M
其他流动负债 $16.98M $13.11M $13.11M $13.11M –
非流动负债合计 $771.32M $774.98M $194.31M $194.31M $210.37M
长期债务及融资租赁负债 $765.10M $769.03M $188.17M $188.17M $192.77M
-长期债务 $586.20M $585.47M – – –
-长期融资租赁负债 $178.90M $183.56M $188.17M $188.17M $192.77M
其他非流动负债 $6.22M $5.95M $6.14M $6.14M $5.28M
股东权益合计 $1.75B $1.81B $1.92B $1.92B $1.92B
股东权益 $1.75B $1.81B $1.92B $1.92B $1.92B
股本 $3.13M $3.12M $3.09M $3.09M $3.01M
-普通股 $3.13M $3.12M $3.09M $3.09M $3.01M
资本公积 $3.91B $3.88B $3.86B $3.86B $3.72B
留存收益 -$2.16B -$2.07B -$1.95B -$1.95B -$1.82B
减:库存股 $60,000.00 $60,000.00 $60,000.00 $60,000.00 $60,000.00
不影响留存收益的损益 -$4.63M -$1.94M $4.82M $4.82M $4.99M
应收款 – – $0.00 $0.00 $0.00
-应收账款 – – $0.00 $0.00 $0.00
一年以上递延负债 – – $0.00 $0.00 $12.32M
投资及预付款 – – – – $28.41M
-可供出售证券 – – – – $28.41M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$83.50M -$108.90M -$345.01M -$92.55M -$84.63M
持续经营经营活动现金流净额 -$83.50M -$108.90M -$345.01M -$92.55M -$84.63M
持续经营净利润 -$91.15M -$122.93M -$581.60M -$130.61M -$106.44M
折旧、折耗与摊销 $4.28M $4.32M $19.48M $5.66M $4.43M
其他非现金项目 -$10.24M $8.80M $72.73M -$8.31M -$10.14M
营运资金变动 -$3.70M -$15.41M $71.88M $22.64M $10.91M
-应收款变动 $0.00 $0.00 $25.00M $0.00 $0.00
-预付资产变动 -$841,000.00 -$247,000.00 $3.34M $3.85M $212,000.00
-应付账款及应计费用变动 -$5.31M -$13.02M $44.89M $4.42M $12.18M
-其他流动负债变动 $4.15M -$199,000.00 $4.26M $13.55M $802,000.00
-其他营运资金变动 -$1.70M -$1.95M -$5.61M $810,000.00 -$2.28M
投资活动现金流净额 -$55.66M -$410.74M -$31.81M $37.20M -$119.23M
持续经营投资活动现金流净额 -$55.66M -$410.74M -$31.81M $37.20M -$119.23M
固定资产购置及出售净额 -$648,000.00 -$504,000.00 -$914,000.00 -$517,000.00 -$74,000.00
投资购置及出售净额 -$52.54M -$410.24M -$5.89M $37.72M -$119.15M
筹资活动现金流 $7.18M $591.91M $426.03M $116.41M $296.77M
持续经营筹资活动现金流净额 $7.18M $591.91M $426.03M $116.41M $296.77M
优先股发行净额 $0.00 $600.00M – – –
股票期权行使所得 $8.30M $6.16M $27.94M $4.92M $18.66M
其他筹资费用净额 -$400,000.00 -$14.25M – – –
期末现金余额 $299.34M $431.31M $359.08M $359.08M $298.02M
现金净变动 -$131.98M $72.27M $49.21M $61.06M $92.91M
期初现金余额 $431.31M $359.08M $309.78M $298.02M $205.14M
汇率变动影响 $6,000.00 -$32,000.00 $95,000.00 $1,000.00 -$27,000.00
自由现金流 -$86.62M -$109.40M -$370.93M -$93.07M -$84.71M
无形资产购置及出售净额 – – -$25.00M $0.00 $0.00
普通股发行净额 – – $398.09M $111.49M $278.11M

讨论区

暂无评论——快来第一个聊聊 CRSP。

登录后参与讨论。

Scroll to Top